Download our free white paper - "Induced Pluripotent Stem Cells: recapitulating disease to facilitate drug discovery"

    Read about how iPSC-derived cells can enhance your drug development research by offering a physiologically relevant model that can represent a disease population enabling research in many different stages of the development pipeline.

    This white paper includes examples where iPSC-derived cells have been used in target identification, target validation, lead optimisation, and safety testing in order to reduce failure rates of drug candidates.

    Download our white paper and discover how hiPSCs are an invaluable tool in drug discovery.

    iPSCs recapitulating disease to facilitate drug discovery

    Read the white paper today!

    Share this post:

    Using hiPSC-Derived Renal Proximal Tubular Cells in vitro assays to advance disease research and drug development

    Using human iPSC-derived cortical neurons for the early prediction of neurotoxicity